Stocks to Watch: Paytm, Mankind Pharma, Cochin Shipyard, Shree Cement | Mint
Active Stocks
Fri Feb 23 2024 15:58:13
  1. Tata Steel share price
  2. 145.50 -0.24%
  1. State Bank Of India share price
  2. 759.40 -0.86%
  1. HDFC Bank share price
  2. 1,420.90 0.08%
  1. NTPC share price
  2. 337.70 -0.54%
  1. ITC share price
  2. 411.60 -0.65%
Business News/ Markets / Stock Markets/  Stocks to Watch: Paytm, Mankind Pharma, Cochin Shipyard, Shree Cement
BackBack

Stocks to Watch: Paytm, Mankind Pharma, Cochin Shipyard, Shree Cement

Here are some stocks to watch out for ahead of Thursday’s trading session.

The RBI has taken action against Paytm Payments Bank, saying no further deposits or credit transactions or top-ups will be allowed in any customer accounts, prepaid instruments, wallets, FASTags, NCMC cards and so on after 29 February. Photo: PixabayPremium
The RBI has taken action against Paytm Payments Bank, saying no further deposits or credit transactions or top-ups will be allowed in any customer accounts, prepaid instruments, wallets, FASTags, NCMC cards and so on after 29 February. Photo: Pixabay

One 97 Communications: The RBI has taken action against Paytm Payments Bank, saying no further deposits or credit transactions or top-ups will be allowed in any customer accounts, prepaid instruments, wallets, FASTags, NCMC cards and so on after 29 February. On 11 March, 2022, the RBI had directed Paytm Payments Bank to stop onboarding of new customers immediately.

Mankind Pharma: Revenue was up 25% to 2,606.9 crore, while Ebitda rose 39% to 606.5 crore in Q3. Ebitda margin up to 23.3% from 20.9% a year ago. Net profit rose 55% to 459.8 crore from 295.7 crore a year ago. Domestic revenue up 20% to 2,400 crore. Export revenue up 118% to 207 crore.

Cochin Shipyard: Bagged an order from a European client to design and build a hybrid service operation vessel (SOV). The project cost is nearly 500 crore and the vessel is to be delivered in 2026.

Glenmark Pharmaceuticals: Joined hands with Pfizer to launch Abrocitinib in India. Abrocitinib is used to treat moderate to severe atopic dermatitis.

Shree Cement: Recorded 165% growth in standalone net profit at 734 crore for the December quarter, with improved realisation and cost reduction amid robust demand growth. Revenue from operations grew 20% to 4,901 crore.

Godrej Consumer Products: Posted 6.4% growth in consolidated profit at 581 crore for the December quarter, with healthy operating numbers. Consolidated revenue from operations increased 1.7% to 3,660 crore from a year ago.

Jindal Steel & Power: Recorded a consolidated profit of 1,928 crore for the December quarter, up 272% from 518 crore a year ago, when it recorded an exceptional loss and higher tax costs. Consolidated revenue from operations fell 6% to 11,701.3 crore.

Dixon Technologies: Posted 87% growth in consolidated net profit at 97 crore for the December quarter, driven by a healthy topline, though the operating margin was weak owing to higher input cost. Revenue from operations doubled to 4,818.3 crore from a year ago.

Divgi TorqTransfer Systems: Won orders worth 212.1 crore from two North American manufacturers of automotive transmissions. The annual value of these five-year orders is about 42.5 crore.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Check all the latest action on Budget 2024 here. Download The Mint News App to get Daily Market Updates.
More Less
Published: 01 Feb 2024, 06:15 AM IST
Next Story footLogo
Recommended For You
GENIE RECOMMENDS

Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!

Let’s get started
Switch to the Mint app for fast and personalized news - Get App